Xconomy

FEBRUARY 15, 2019

Section 32, a venture capital firm headquartered near San Diego that launched in 2017 with a $151 million fund, has had a big month. In an interview with Xconomy last year , the former Googler said his firm planned to focus most of its attention on investments at the juncture of life sciences and information technology.

San Diego 78

San Diego Funding Venture Capital Google 78

Xconomy

OCTOBER 23, 2018

The buyout comes almost two years after Carlsbad, CA-based Genoptix was bought from Novartis (NYSE: NVS ) by a pair of private investment firms, Ampersand Capital Partners and 1315 Capital, and a management group for an undisclosed sum in January 2017. Joseph Limber became the CEO of the company.

San Diego 83

San Diego Capital Invest Startup 83

Xconomy

DECEMBER 28, 2017

Guengerich moved to North Texas in 2017 after years in the Austin tech community, where he co-founded Appconomy, a China-focused e-commerce startup, among other initiatives. Here’s an edited transcript. Read more » Reprints | Share:

Social Media 65

Social Media Commerce Web Media 65

Xconomy

JANUARY 24, 2019

The team at Trust & Will, a San Diego-based startup founded in October of 2017, is betting that a good chunk of those people would shell out some money to outline an estate plan if the process were cheaper and easier. [ Updated 9:30 a.m., million in seed—in 2018 to advance its growing suite of products, digitized.

San Diego 73

San Diego Seed Funding Funding Startup 73

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

JANUARY 9, 2019

Venture capital investments rose in 2018 to levels not seen since the heady days of 2000, the last year U.S. That was about 500 fewer deals than in the year prior, but the total amount invested increased by $47.9 billion compared to 2017, continuing a trend of bigger checks going to fewer deals. billion into companies.

Venture Capital 86

Venture Capital Invest Report Capital 86

Xconomy

JULY 19, 2019

In late 2017, a federal watchdog unit assigned a working group to keep an eye on cryptocurrencies such as Bitcoin, and to sound an alert if those alternate currencies showed signs of becoming a risk to the stability of the US financial system.

Pricing 89

Pricing Report Invest Venture Capital 89

Xconomy

DECEMBER 5, 2018

Steven Burrill, once a noted biotech investment fund founder, sought-after conference speaker, and life sciences publisher, was sentenced Wednesday to serve 30 months in federal prison for defrauding his investors and evading taxes. Burrill was indicted by a federal grand jury on September 14, 2017.

Venture Capital 70

Venture Capital Conference Funding Invest 70

Xconomy

APRIL 9, 2018

billion that VCs invested in the first quarter of 2017. billion that PitchBook counted in the first quarter was a third higher than the $21.3 billion that VCs deployed in the previous quarter and two-thirds more than the $16.9 The venture deal count, however, is another matter altogether. The 1,683 venture deals that.

Venture Capital 74

Venture Capital Funding Capital Report 74

Xconomy

APRIL 4, 2017

billion , they also eased off the throttle in terms of their investment activity during the first quarter of 2017, according to data released today by Seattle-based PitchBook and the National Venture Capital Association (NVCA). According to the latest Venture Monitor report, VCs invested slightly more than $16.5

Venture Capital 57

Venture Capital Funding Activity Report 57

Xconomy

OCTOBER 9, 2017

Venture firms invested $21.5 billion in 1,699 startups nationwide during the quarter, maintaining a pace that could reach a decade high by the end of 2017 in terms of overall funding. The quarterly Venture Monitor report is set for release today by Seattle-based PitchBook and the National Venture Capital Association (NVCA).

Venture Capital 66

Venture Capital Funding Report Capital 66

Xconomy

SEPTEMBER 16, 2019

The San Francisco-based construction tech company says it raised $8.5 million in a Series B funding round in 2017, and it has just added another $25 million from a Series C funding round led by veteran Silicon Valley venture capital firm Menlo Ventures. million across two newly disclosed fundraising rounds.

Venture Capital 70

Venture Capital Mobile Funding Capital 70

Xconomy

JANUARY 3, 2020

If you’re keeping score, that compares with 59 approvals in 2018 and 46 in 2017. The decisions covered insomnia, migraine, and several different forms of cancer. The FDA’s final tally for the year totaled 48 new drug approvals.

San Diego 57

San Diego Blogging Invest Startup 57

Xconomy

APRIL 23, 2018

Unit sales rose 279 percent from 2016 to 2017, according to the association. “We The Consumer Technology Association estimates that nearly 44 million voice-enabled assistants will be sold this year in the United States. We have entered the era of voice ,” Jim Harris, a management consultant writes on the CTA’s website.

Writing 66

Writing Sales Technology Social Media 66

Xconomy

FEBRUARY 2, 2018

The President credited the FDA for a record number of generic drug approvals in 2017, which PwC notes is part of a trend that began three years ago. At one hour and 20 minutes, President Trump fell about 9 minutes shy of the high mark. But those who stayed tuned in heard comments about several health policy matters.

San Diego 56

San Diego Blogging Invest Startup 56

Xconomy

AUGUST 23, 2016

The discussion came to a boil earlier this year after a small New York investment bank hired scantily-clad women to attend its cocktail party at the J.P. LifeSci Advisors cofounder and CEO Andrew McDonald told Xconomy in May that his firm would help place 15 women on boards by the end of 2017. Morgan conference in January.

Training 40

Training Class Organization Course 40

Xconomy

NOVEMBER 11, 2016

—A month after Cambridge, MA-based Merrimack Pharmaceuticals (NASDAQ: MACK ) restructured and its CEO resigned , Reuters reported that the company has hired investment bankers to explore a possible sale. The company has cut 21 jobs since pricing its IPO and cut a deal to defer debt payments until August 2017.

Patents 87

Patents Study Pricing Technical Review 87

Xconomy

AUGUST 12, 2016

The new company, expected to launch in 2017, will trade on the Nasdaq under the symbol “BIVV” when the split is complete. The news was a relief for Redwood City, CA-based Heron, which has been waiting for word on the status of its drug since September 2015. Its financials were posted here. In the U.S.,

Google 40

Google Technical Review News Research 40

Xconomy

AUGUST 26, 2016

. —Cambridge-based startup Amylyx Pharmaceuticals raised a $5 million Series A round from Morningside Venture, the ALS Investment Fund, and former Genzyme CEO Henri Termeer to develop a drug meant to stop the death of nerve cells in patients with amyotrophic lateral sclerosis.

Pricing 40

Pricing Thousand Oaks Startup Research 40